Related Experiment Video

Updated: Jul 16, 2026

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery

M Golzio1, L Mazzolini, A Ledoux

  • 1IPBS CNRS, Toulouse, France.

Gene Therapy
|March 9, 2007
PubMed

Insights

Electrically mediated delivery effectively transports short interfering RNAs (siRNAs) into solid tumors, enabling gene silencing. This method shows promise for targeted cancer therapies by overcoming delivery challenges.

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Cancer Research

Background:

  • RNA interference (RNAi) offers targeted gene inhibition for therapies.
  • Efficient delivery of RNAi molecules (siRNAs, shRNAs) to target tissues is a major challenge.
  • Developing effective delivery methods into solid tumors is critical for cancer treatment.

Purpose of the Study:

  • To investigate electrically mediated delivery of siRNA into murine solid tumors.
  • To assess the efficiency of siRNA delivery and subsequent gene silencing in vivo.

Main Methods:

  • Utilized murine tumors engineered to express a target reporter gene (enhanced green fluorescent protein - EGFP).
  • Employed electrically mediated methods for siRNA delivery into the tumors.
  • Quantified EGFP gene silencing over time using fluorescence imaging in live animals.

Main Results:

  • Demonstrated that electric fields facilitate efficient siRNA delivery into solid tumor cells.
  • Confirmed successful gene silencing of the target EGFP reporter gene.
  • Showcased the potential for in vivo monitoring of gene silencing efficacy.

Conclusions:

  • Electrically mediated delivery is an effective strategy for siRNA delivery into solid tumors.
  • This approach enables targeted gene silencing within the tumor microenvironment.
  • Electric field-based delivery holds significant promise for advancing RNAi-based cancer therapeutics.

More Related Videos

High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays (MEA)09:14

High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays (MEA)

Published on: September 13, 2012

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...